18F-FDG super bone marrow uptake: A highly potent indicator for the malignant infiltration. - Wikidata - wikimedia - TriplyDB

18F-FDG super bone marrow uptake: A highly potent indicator for the malignant infiltration.

18F-FDG super bone marrow uptake: A highly potent indicator for the malignant infiltration.

http://www.wikidata.org/entity/Q37552097

about

Renal osteodystrophy presenting as a metabolic superscan on F-18 FDG PET/CT: A case report.A predicting model of bone marrow malignant infiltration in 18F-FDG PET/CT images with increased diffuse bone marrow FDG uptake.

P2860

Q46201766-5E4C467A-1778-43F3-B498-862A379115BC Q55284893-BB7357CE-73EF-4579-8376-B93C73C3615E

P2860

18F-FDG super bone marrow uptake: A highly potent indicator for the malignant infiltration.

http://www.wikidata.org/entity/Q37552097

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

18F-FDG super bone marrow upta ...... or the malignant infiltration.

@en

18F-FDG super bone marrow upta ...... or the malignant infiltration.

@nl

type

label

18F-FDG super bone marrow upta ...... or the malignant infiltration.

@en

18F-FDG super bone marrow upta ...... or the malignant infiltration.

@nl

prefLabel

18F-FDG super bone marrow upta ...... or the malignant infiltration.

@en

18F-FDG super bone marrow upta ...... or the malignant infiltration.

@nl

P1433

Q37552097-23FC6301-2AFB-4979-84ED-0F65A9FCB11A

P1476

Q37552097-1C2EA7C8-32DF-4CD3-BD4E-C806296E341B

P2093

Q37552097-0443C77A-C1E6-40B6-9132-01A0ABBE5D79

Q37552097-0A48E10D-28EE-4ADC-88EA-A2885ED62402

Q37552097-3034D73A-69FC-47EE-BE0A-068778F3AE9B

Q37552097-56397545-84A1-431F-9CFA-B8A080F91F85

Q37552097-635EE373-3C7D-4EE9-810C-90DE569F1375

Q37552097-7C460087-0419-4D7E-9B4E-31CCBB0B227D

Q37552097-AC6F5457-E2C1-4B2C-B845-B50E6A534B5F

Q37552097-B6ECD190-885E-438F-824A-2750CEF7450C

Q37552097-D7528016-B063-445D-9917-DCBD0E2D69ED

P2860

Q37552097-0129C9AC-9FC3-4809-BDE9-9A2C923B9B9B

Q37552097-022E3452-1FEA-45D5-A09D-D6DC6D92192A

Q37552097-0BBB797C-A7AB-42B8-8620-2E6D4D85A241

Q37552097-135C661B-E539-4936-AB7D-93223F3D30D0

Q37552097-15DBE172-0F2B-40A4-BFC4-3AA31D4C0315

Q37552097-169062AD-8466-4BF4-96AF-ECB9C64A7305

Q37552097-1C309016-327A-408E-B12A-56986166652F

Q37552097-23C52FA7-1147-451E-ADF8-2EAF140971B0

Q37552097-277F4963-9FFA-4D87-B928-A7B40CEA4E70

Q37552097-29BC93BD-A207-46DF-97AF-15957C5177D4

P304

Q37552097-25482B6D-4086-4D3F-8BC3-8F0A15DC74FE

P31

Q37552097-8A934409-572E-46FD-904F-D869DD75E897

P356

Q37552097-F6E7B71F-1C14-4088-B336-F15F416C21BF

P407

Q37552097-A85F111C-8C37-4B35-8A1A-B1279B117A5A

P433

Q37552097-F1A4342C-6CAD-415E-A2EA-9B6B2B41DA26

P478

Q37552097-A19603A8-C42B-410B-B02A-F25637A57E0C

P577

Q37552097-45A18877-FAB1-4C60-8DE7-BDE9A6074F85

P698

Q37552097-5EF5E669-1C93-41AE-8A28-A98DF57FA0B3

P932

Q37552097-74EE9434-032D-4E8C-8962-5B5281B36771

P356

MD.0000000000005579

P1433

P1476

18F-FDG super bone marrow upta ...... or the malignant infiltration.

@en

P2093

Hong-Sheng Li

http://www.w3.org/2001/XMLSchema#string

Hu-Bing Wu

http://www.w3.org/2001/XMLSchema#string

Lilan Fu

http://www.w3.org/2001/XMLSchema#string

Mohammed Shah Alam

http://www.w3.org/2001/XMLSchema#string

Quan-Shi Wang

http://www.w3.org/2001/XMLSchema#string

Wen-Lan Zhou

http://www.w3.org/2001/XMLSchema#string

Yan-Jiang Han

http://www.w3.org/2001/XMLSchema#string

Yun-Yan Ren

http://www.w3.org/2001/XMLSchema#string

Zhen Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Improving patient selection for 18F-FDG PET scanning in the staging of gastric cancer

The alteration of 18F-FDG uptake in bone marrow after treatment with interleukin 11.

Usefulness of (18)F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Patients with High-Grade Non-Hodgkin's Lymphoma.

Oncogene pathway activation in mammary tumors dictates FDG-PET uptake

Diagnostic Performance of ¹⁸F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis.

Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.

Clinical utility of FDG-PET and PET/CT in non-malignant thoracic disorders.

Primary bone marrow diffuse large B cell lymphoma: a case series and review.

False-positive uptake on 2-[¹⁸F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging.

FDG PET/CT imaging as a biomarker in lymphoma.

P304

e5579

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000005579

http://www.w3.org/2001/XMLSchema#string

P407

P433

52

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28033252

http://www.w3.org/2001/XMLSchema#string

P932

5207548

http://www.w3.org/2001/XMLSchema#string